These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 35729310)
1. Use of rituximab in SARS-CoV-2-positive renal transplant recipient with EBV reactivation and probable haemophagocytic lymphohistiocytosis. Chan D; Karimi S; Follows G; Torpey N; Suchanek O CEN Case Rep; 2023 Feb; 12(1):27-31. PubMed ID: 35729310 [TBL] [Abstract][Full Text] [Related]
2. Combining an antiviral with rituximab in EBV-related haemophagocytic lymphohistiocytosis led to rapid viral clearance; and a comprehensive review. Stefanou C; Tzortzi C; Georgiou F; Timiliotou C BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 27941111 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Chellapandian D; Das R; Zelley K; Wiener SJ; Zhao H; Teachey DT; Nichols KE; Br J Haematol; 2013 Aug; 162(3):376-82. PubMed ID: 23692048 [TBL] [Abstract][Full Text] [Related]
4. Rescue of HLH with T and B Lymphocyte Involvement Due to Epstein-Barr Virus by PD-1 Inhibitor/Ruxolitinib and Rituximab Combination Regimens: A Case Report. Zhu M; Zhang J; Shi Q; Sun X; Wang H; Sun M; Liu Y Iran J Immunol; 2023 Dec; 20(4):466-472. PubMed ID: 37873944 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 Complications in a Newly Diagnosed HIV Patient: A Case of Multiple Herpesvirus Reactivation and HLH Post-ART Initiation. Davari S; Taunk PS; Madaline T Am J Case Rep; 2023 Jul; 24():e939847. PubMed ID: 37452490 [TBL] [Abstract][Full Text] [Related]
8. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes. El-Mallawany NK; Curry CV; Allen CE Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507 [TBL] [Abstract][Full Text] [Related]
9. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications. Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118 [TBL] [Abstract][Full Text] [Related]
10. Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection. Li Y; Li S; Lu N; Wang W; Wang D Ann Hematol; 2024 May; 103(5):1541-1547. PubMed ID: 38467825 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus induced haemophagocytic lymphohistiocytosis. Zimmer M; Gill I; Anusim N; Gaikazian SS BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33952568 [TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group. Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916 [TBL] [Abstract][Full Text] [Related]
14. Dual Threat of Epstein-Barr Virus: an Autopsy Case Report of HIV-Positive Plasmablastic Lymphoma Complicating EBV-Associated Hemophagocytic Lymphohistiocytosis. Koizumi Y; Imadome KI; Ota Y; Minamiguchi H; Kodama Y; Watanabe D; Mikamo H; Uehira T; Okada S; Shirasaka T J Clin Immunol; 2018 May; 38(4):478-483. PubMed ID: 29687211 [TBL] [Abstract][Full Text] [Related]
15. Crohn's disease complicated by Epstein-Barr virus-driven haemophagocytic lymphohistiocytosis successfully treated with rituximab. Thompson G; Pepperell D; Lawrence I; McGettigan BD BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28228435 [TBL] [Abstract][Full Text] [Related]
16. L-DEP regimen salvage therapy for paediatric patients with refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis. Zhao Y; Li Z; Zhang L; Lian H; Ma H; Wang D; Zhao X; Zhang Q; Wang T; Zhang R Br J Haematol; 2020 Nov; 191(3):453-459. PubMed ID: 32525580 [TBL] [Abstract][Full Text] [Related]
17. Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection. Meng GQ; Wang JS; Wang YN; Wei N; Wang Z Int Immunopharmacol; 2021 Jul; 96():107606. PubMed ID: 33826999 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Yin Q; Wang J; Wang Z Ann Hematol; 2022 Nov; 101(11):2471-2476. PubMed ID: 36071294 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-related hemophagocytic lymphohistiocytosis complicated with coronary artery dilation and acute renal injury in a boy with a novel X-linked inhibitor of apoptosis protein (XIAP) variant: a case report. Chen RY; Li XZ; Lin Q; Zhu Y; Shen YY; Xu QY; Zhu XM; Bai ZJ; Li Y BMC Pediatr; 2020 Oct; 20(1):456. PubMed ID: 33008347 [TBL] [Abstract][Full Text] [Related]
20. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis subsequent to rabbit antithymocyte globulin administration and successfully treated with rituximab in a patient with aplastic anemia]. Nagata H; Fujino T; Muramatsu A; Kawaji Y; Kuriyama K; Oshiro M; Hirakawa Y; Iwai T; Uchiyama H Rinsho Ketsueki; 2018; 59(4):407-413. PubMed ID: 29743400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]